We are live on ! Find out more
WINT

Windtree Therapeutics Inc

Delisted

WINT was delisted on the 4th of May, 2017.

34 hedge funds and large institutions have $5.83M invested in Windtree Therapeutics Inc in 2016 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 9 increasing their positions, 20 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

16,700% more call options, than puts

Call options by funds: $336K | Put options by funds: $2K

36% less funds holding

Funds holding: 5334 (-19)

48% less capital invested

Capital invested by funds: $11.2M → $5.83M (-$5.39M)

55% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 20

90% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 21

Holders
34
Holders Change
-19
Holders Change %
-35.85%
% of All Funds
0.91%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
9
Reduced
20
Closed
21
Calls
$336K
Puts
$2K
Net Calls
+$334K
Net Calls Change
-$7.16M
Name Holding Trade Value Shares
Change
Change in
Stake
Manulife (Manufacturers Life Insurance)
51
Manulife (Manufacturers Life Insurance)
Ontario, Canada
-$2 -1 -3%
Royal Bank of Canada
52
Royal Bank of Canada
Ontario, Canada
-$2 -1 -3%

WINT Hedge Fund Activity: Q1 2016 in Review

34 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in Windtree Therapeutics Inc (WINT) for Q1 2016, worth a combined $5.83M — down 48% from $11.2M a quarter earlier.

Sellers outnumbered buyers: 21 funds closed out of WINT and 2 opened new positions — a net loss of 19 holders — while 20 trimmed existing stakes and 9 added.

The largest buyer was Sabby Management, adding an estimated $90.4K. The largest seller was Laurion Capital Management, exiting entirely with an estimated $278K sold.

  • 34 institutional investors held Windtree Therapeutics Inc (WINT) as of Q1 2016, down from 53 in Q4 2015.
  • Funds reported $5.83M of Windtree Therapeutics Inc stock for Q1 2016, down 48% quarter-over-quarter.
  • 2 funds opened new Windtree Therapeutics Inc positions in Q1 2016 and 21 closed out, a net change of -19 holders.
  • The largest Windtree Therapeutics Inc buyer in Q1 2016 was Sabby Management, an estimated $90.4K added.
  • The largest Windtree Therapeutics Inc seller in Q1 2016 was Laurion Capital Management, an estimated $278K sold.

Based on aggregated 13F filings for Q1 2016.